Table 1 Key demographic and clinical characteristics of 179 patients with localized NB >18 months
Characteristic | No. | % |
|---|---|---|
Sex | ||
male | 86 | 48.0 |
female | 93 | 52.0 |
Primary tumor site | ||
Neck | 4 | 2.2 |
Chest | 38 | 21.2 |
Abdomen | 47 | 26.3 |
Adrenal | 80 | 44.7 |
Pelvis | 7 | 3.9 |
combined | 3 | 1.7 |
MYCN status | ||
non-amplified | 140 | 78.2 |
amplified | 36 | 20.1 |
not available | 3 | 1.7 |
INSS stage | ||
stage 1 | 68 | 38.0 |
stage 2 | 46 | 25.7 |
stage 3 | 65 | 36.3 |
NB97 risk group | ||
low | 96 | 53.6 |
standard | 36 | 20.1 |
high | 47 | 26.1 |
IDRF | ||
yes | 70 | 39.1 |
no | 73 | 40.8 |
not available | 36 | 20.1 |
INRG risk group | ||
very low | 88 | 49.2 |
low | 4 | 2.2 |
intermediate | 23 | 12.8 |
high | 36 | 20.1 |
not available | 28 | 15.6 |
First operation | ||
biopsy only | 69 | 38.5 |
incomplete resection | 13 | 7.3 |
gross total resection | 14 | 7.8 |
complete resection | 83 | 46.4 |
Last operation | ||
biopsy only | 0 | 0 |
incomplete resection | 17 | 9.5 |
gross total resection | 20 | 11.2 |
complete resection | 40 | 22.3 |
Best operation | ||
biopsy only | 1 | 0.6 |
incomplete resection | 25 | 14.0 |
gross total resection | 30 | 16.8 |
complete resection | 123 | 68.7 |
Chemotherapy | ||
yes | 82 | 45.8 |
no | 97 | 54.2 |
RT of primary tumor site | ||
yes | 7 | 3.9 |
no | 172 | 96.1 |
myeloablative Chemo with ASCT | ||
yes | 23 | 12.8 |
no | 156 | 87.2 |